Search clinical trials for: Galvus (vildagliptin)
Total 261 results
-
Ziv HospitalUnknownNon-Alcoholic Fatty Liver DiseaseIsrael
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Germany, Switzerland
-
Rio de Janeiro State UniversityLaboratory for Clinical and Experimental Research on Vascular BiologyCompleted1- Microvascular Function | 2-oxidative Stress | 3-inflammationBrazil
-
University Hospital, Strasbourg, FranceNovartisCompleted
-
Korea University Anam HospitalUnknownDiabetes Mellitus | Oxidative StressKorea, Republic of
-
Pusan National University HospitalCompletedType 2 DiabetesKorea, Republic of
-
Peking UniversityUnknownObesity | Diabetes Mellitus, Type 2China
-
SanofiCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusEgypt, United Kingdom, Turkey, Lebanon, Russian Federation, Tunisia, Malaysia, Germany, Spain, Saudi Arabia, Denmark, Indonesia, Jordan, Kuwait, Singapore, United Arab Emirates
-
Hospital de Clinicas de Porto AlegreUnknownDiabetes Mellitus, Type 2 | Exercise | Hypoglycemic Agents | Diabetic Blood Glucose MonitoringBrazil
-
Royal Devon and Exeter NHS Foundation TrustNovartis Pharmaceuticals; National Institute for Health Research, United KingdomCompletedInsulin Resistance | Microvascular DiseaseUnited Kingdom
-
NovartisTerminatedDiabetes Mellitus, Type 2United States
-
Johann Wolfgang Goethe University HospitalWithdrawnSDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV InhibitorsGermany
-
University Hospital, ToulouseNovartis Pharmaceuticals; Institute of Molecular Medicine of Rangueil (I2MR); Faculty of Medicine, ToulouseCompletedDiabetes MellitusFrance
-
Yaounde Central HospitalUniversity of Yaounde 1; University of BueaCompletedType 2 Diabetes MellitusCameroon
-
Merck Sharp & Dohme LLCCompleted
-
Genuine Research Center, EgyptEva PharmaCompleted
-
Centre Hospitalier Universitaire de BesanconUniversity Hospital, Strasbourg, France; Centre Hospitalier Universitaire de... and other collaboratorsRecruitingDiabetes | Disorder Related to Renal TransplantationFrance
-
NovartisCompletedDiabetes Mellitus, Type 2Spain, Argentina, Russian Federation, Norway, India, Sweden, Finland, France, Canada, Germany, Australia, Costa Rica
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Taiwan
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusChina, Thailand, Philippines, Singapore
-
Lund UniversityCompletedHypoglycemia | DiabetesSweden
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompleted
-
Handok Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
Federal University of São PauloNovartisUnknownType 1 Diabetes | Autoimmune Diabetes | Insulin Dependent Diabetes | Juvenile Onset Diabetes MellitusBrazil
-
Marcus SaemannCompletedKidney Transplantation | Impaired Glucose ToleranceAustria
-
Centro de Diabetes Curitiba LtdaCompletedType 2 Diabetes Mellitus | Menopause | Osteoporosis | OsteopeniaBrazil
-
Novartis PharmaceuticalsCompletedType 2 Diabetes Mellitus (T2DM)France
-
Dr. José Fernando Vilela-Martin MD PhDNovartisCompletedHypertension | Type 2 Diabetes Mellitus | Endothelial DysfunctionBrazil
-
Lund UniversityCompleted
-
Seoul National University Bundang HospitalCompletedDiabetesKorea, Republic of
-
Damanhour UniversityTanta UniversityCompletedCoronary Artery Disease | Diabetes Mellitus, Type 2Egypt
-
Laboratorios Silanes S.A. de C.V.Recruiting
-
Lin LiaoUnknownType 2 Diabetes MellitusChina
-
Novartis PharmaceuticalsCompletedType II Diabetes Mellitus | Congestive Heart FailureRussian Federation, Singapore, Italy, Czechia, Lithuania, Germany, Guatemala, India, Denmark, Estonia, Slovakia, Romania, Latvia, Greece, Poland
-
Lund UniversityCompleted
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusSpain, Poland, South Africa, Taiwan, Hong Kong, Norway, Italy, Bulgaria, Latvia, Lithuania, Germany, Turkey, Argentina, Israel, Korea, Republic of, Dominican Republic, Guatemala, Brazil, Colombia, Peru, Philippines, Russian Federation and more
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
NovartisCompleted
-
Piemonti LorenzoItalian Diabetes FoundationCompletedDiabetes Mellitus, Type 1Italy
-
Heidelberg UniversityUnknown
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
Bio-innova Co., LtdNot yet recruiting
-
Radboud University Medical CenterCompletedType 2 Diabetes | Endothelial DysfunctionNetherlands
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Germany
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States